{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:33:18Z","timestamp":1791369198633,"version":"4.3.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00277-021-04640-7","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:01:56Z","timestamp":1630706516000},"page":"2787-2797","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Outcome of allogeneic hematopoietic stem cell transplant recipients admitted to the intensive care unit with a focus on haploidentical graft and sequential conditioning regimen: results of a retrospective study"],"prefix":"10.1007","volume":"100","author":[{"given":"Viviane","family":"Gournay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Dumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-R\u00e9mi","family":"Lavillegrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Hariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Urbina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Baudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafid","family":"Ait-Oufella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Maury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eolia","family":"Brissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ollivier","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Malard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Guidet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Dul\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2945-6293","authenticated-orcid":false,"given":"Na\u00efke","family":"Big\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"4640_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354:1813\u20131826. https:\/\/doi.org\/10.1056\/NEJMra052638","journal-title":"N Engl J Med"},{"key":"4640_CR2","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1038\/s41409-019-0465-9","volume":"54","author":"JR Passweg","year":"2019","unstructured":"Passweg JR, Baldomero H, Basak GW et al (2019) The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplant 54:1575\u20131585. https:\/\/doi.org\/10.1038\/s41409-019-0465-9","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR3","unstructured":"Agence Nationale de la Biom\u00e9decine (2018) National activity of hematopoietic stem cell transplantation: medical and scientific report 2018"},{"key":"4640_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/blood-2014-02-514745","volume":"124","author":"KA Markey","year":"2014","unstructured":"Markey KA, MacDonald KPA, Hill GR (2014) The biology of graft-versus-host disease: experimental systems instructing clinical practice. Blood 124:354\u2013362. https:\/\/doi.org\/10.1182\/blood-2014-02-514745","journal-title":"Blood"},{"key":"4640_CR5","doi-asserted-by":"publisher","unstructured":"Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, von Bergwelt-Baildon M, Cochrane Haematological Malignancies Group (2014) Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Cochrane Database Syst Rev CD010189. https:\/\/doi.org\/10.1002\/14651858.CD010189.pub2","DOI":"10.1002\/14651858.CD010189.pub2"},{"key":"4640_CR6","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M, van Besien K, Rond\u00f3n G, Anderlini P, O'Brien S, Khouri I, Gajewski J, Mehra R, Claxton D, Andersson B, Beran M, Przepiorka D, Koller C, Kornblau S, K\u00f6rbling M, Keating M, Kantarjian H, Champlin R (1997) Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 89:4531\u20134536","journal-title":"Blood"},{"key":"4640_CR7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jcrc.2015.06.020","volume":"30","author":"D Mokart","year":"2015","unstructured":"Mokart D, Granata A, Crocchiolo R, Sannini A, Chow-Chine L, Brun JP, Bisbal M, Faucher M, Faucher C, Blache JL, Castagna L, F\u00fcrst S, Blaise D (2015) Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: outcomes of patients admitted to intensive care unit. J Crit Care 30:1107\u20131113. https:\/\/doi.org\/10.1016\/j.jcrc.2015.06.020","journal-title":"J Crit Care"},{"key":"4640_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3324\/haematol.2018.189258","volume":"103","author":"D Salvatore","year":"2018","unstructured":"Salvatore D, Labopin M, Ruggeri A, Battipaglia G, Ghavamzadeh A, Ciceri F, Blaise D, Arcese W, Soci\u00e8 G, Bourhis JH, van Lint MT, Bruno B, Huynh A, Santarone S, Deconinck E, Mohty M, Nagler A (2018) Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica. 103:1317\u20131328. https:\/\/doi.org\/10.3324\/haematol.2018.189258","journal-title":"Haematologica."},{"key":"4640_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/bmt.2017.34","volume":"52","author":"JR Passweg","year":"2017","unstructured":"Passweg JR, Baldomero H, Bader P et al (2017) Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 52:811\u2013817. https:\/\/doi.org\/10.1038\/bmt.2017.34","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3324\/haematol.2016.150326","volume":"102","author":"M Mohty","year":"2017","unstructured":"Mohty M, Malard F, Blaise D, Milpied N, Soci\u00e9 G, Huynh A, Reman O, Yakoub-Agha I, Furst S, Guillaume T, Tabrizi R, Vigouroux S, Peterlin P, el-Cheikh J, Moreau P, Labopin M, Chevallier P (2017) Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia. Haematologica 102:184\u2013191. https:\/\/doi.org\/10.3324\/haematol.2016.150326","journal-title":"Haematologica"},{"key":"4640_CR11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbmt.2018.01.005","volume":"24","author":"R Dul\u00e9ry","year":"2018","unstructured":"Dul\u00e9ry R, M\u00e9nard A-L, Chantepie S, el-Cheikh J, Fran\u00e7ois S, Delage J, Giannotti F, Ruggeri A, Brissot E, Battipaglia G, Malard F, Belhocine R, Sestili S, Vekhoff A, Delhommeau F, Reman O, Legrand O, Labopin M, Rubio MT, Mohty M (2018) Sequential conditioning with thiotepa in T cell-replete hematopoietic stem cell transplantation for the treatment of refractory hematologic malignancies: comparison with matched related, haplo-mismatched, and unrelated donors. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 24:1013\u20131021. https:\/\/doi.org\/10.1016\/j.bbmt.2018.01.005","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"4640_CR12","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1200\/JCO.2013.50.5867","volume":"31","author":"UD Bayraktar","year":"2013","unstructured":"Bayraktar UD, Shpall EJ, Liu P, Ciurea SO, Rondon G, de Lima M, Cardenas-Turanzas M, Price KJ, Champlin RE, Nates JL (2013) Hematopoietic cell transplantation\u2013specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol 31:4207\u20134214. https:\/\/doi.org\/10.1200\/JCO.2013.50.5867","journal-title":"J Clin Oncol"},{"key":"4640_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/bjh.12294","volume":"161","author":"WM Townsend","year":"2013","unstructured":"Townsend WM, Holroyd A, Pearce R, Mackinnon S, Naik P, Goldstone AH, Linch DC, Peggs KS, Thomson KJ, Singer M, Howell DCJ, Morris EC (2013) Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. Br J Haematol 161:578\u2013586. https:\/\/doi.org\/10.1111\/bjh.12294","journal-title":"Br J Haematol"},{"key":"4640_CR14","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/bmt.2015.55","volume":"50","author":"E Lenglin\u00e9","year":"2015","unstructured":"Lenglin\u00e9 E, Chevret S, Moreau A-S, P\u00e8ne F, Blot F, Bourhis JH, Buzyn A, Schlemmer B, Soci\u00e9 G, Azoulay E (2015) Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 50:840\u2013845. https:\/\/doi.org\/10.1038\/bmt.2015.55","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1200\/JCO.2005.03.9073","volume":"24","author":"F P\u00e8ne","year":"2006","unstructured":"P\u00e8ne F, Aubron C, Azoulay E, Blot F, Thi\u00e9ry G, Raynard B, Schlemmer B, Nitenberg G, Buzyn A, Arnaud P, Soci\u00e9 G, Mira JP (2006) Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 24:643\u2013649. https:\/\/doi.org\/10.1200\/JCO.2005.03.9073","journal-title":"J Clin Oncol"},{"key":"4640_CR16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/bmt.2009.220","volume":"45","author":"K Gilli","year":"2010","unstructured":"Gilli K, Remberger M, Hjelmqvist H, Ringden O, Mattsson J (2010) Sequential organ failure assessment predicts the outcome of SCT recipients admitted to intensive care unit. Bone Marrow Transplant 45:682\u2013688. https:\/\/doi.org\/10.1038\/bmt.2009.220","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR17","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1186\/cc6923","volume":"12","author":"DC Scales","year":"2008","unstructured":"Scales DC, Thiruchelvam D, Kiss A, Sibbald WJ, Redelmeier DA (2008) Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Crit Care Lond Engl 12:R77. https:\/\/doi.org\/10.1186\/cc6923","journal-title":"Crit Care Lond Engl"},{"key":"4640_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0929-6646(09)60255-2","volume":"106","author":"T-M Yang","year":"2007","unstructured":"Yang T-M, Wang P-N, Kao K-C, Huang CC, Tsai YH, Hsieh MJ (2007) Outcome of hematopoietic stem cell recipients who were mechanically ventilated and admitted to intensive care units. J Formos Med Assoc Taiwan Yi Zhi 106:295\u2013301. https:\/\/doi.org\/10.1016\/S0929-6646(09)60255-2","journal-title":"J Formos Med Assoc Taiwan Yi Zhi"},{"key":"4640_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/bmt.2015.269","volume":"51","author":"L Platon","year":"2016","unstructured":"Platon L, Amigues L, Ceballos P, Fegueux N, Daubin D, Besnard N, Larcher R, Landreau L, Agostini C, Machado S, Jonquet O, Klouche K (2016) A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009\u20132013). Bone Marrow Transplant 51:256\u2013261. https:\/\/doi.org\/10.1038\/bmt.2015.269","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR20","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/sj.bmt.1705502","volume":"38","author":"N Naeem","year":"2006","unstructured":"Naeem N, Eyzaguirre A, Kern JA, Lazarus HM, Hejal RB, Laughlin MJ, Kern EFO (2006) Outcome of adult umbilical cord blood transplant patients admitted to a medical intensive care unit. Bone Marrow Transplant 38:733\u2013738. https:\/\/doi.org\/10.1038\/sj.bmt.1705502","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR21","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.bbmt.2012.02.009","volume":"18","author":"M Solh","year":"2012","unstructured":"Solh M, Oommen S, Vogel RI, Shanley R, Majhail NS, Burns LJ (2012) A prognostic index for survival among mechanically ventilated hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 18:1378\u20131384. https:\/\/doi.org\/10.1016\/j.bbmt.2012.02.009","journal-title":"Biol Blood Marrow Transplant"},{"key":"4640_CR22","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/bmt.2014.130","volume":"49","author":"V Allareddy","year":"2014","unstructured":"Allareddy V, Roy A, Rampa S, Lee MK, Nalliah RP, Allareddy V, Rotta AT (2014) Outcomes of stem cell transplant patients with acute respiratory failure requiring mechanical ventilation in the United States. Bone Marrow Transplant 49:1278\u20131286. https:\/\/doi.org\/10.1038\/bmt.2014.130","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.bbmt.2012.09.010","volume":"19","author":"C Gilbert","year":"2013","unstructured":"Gilbert C, Vasu TS, Baram M (2013) Use of mechanical ventilation and renal replacement therapy in critically ill hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 19:321\u2013324. https:\/\/doi.org\/10.1016\/j.bbmt.2012.09.010","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"4640_CR24","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/bmt.2010.255","volume":"46","author":"P Depuydt","year":"2011","unstructured":"Depuydt P, Kerre T, Noens L, Nollet J, Offner F, Decruyenaere J, Benoit D (2011) Outcome in critically ill patients with allogeneic BM or peripheral haematopoietic SCT: a single-centre experience. Bone Marrow Transplant 46:1186\u20131191. https:\/\/doi.org\/10.1038\/bmt.2010.255","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/bmt.2013.141","volume":"49","author":"R Benz","year":"2014","unstructured":"Benz R, Schanz U, Maggiorini M, Seebach JD, Stussi G (2014) Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT. Bone Marrow Transplant 49:62\u201365. https:\/\/doi.org\/10.1038\/bmt.2013.141","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/10428194.2016.1195499","volume":"58","author":"S Mayer","year":"2017","unstructured":"Mayer S, Pastores SM, Riedel E, Maloy M, Jakubowski AA (2017) Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peri-transplant period. Leuk Lymphoma 58:382\u2013390. https:\/\/doi.org\/10.1080\/10428194.2016.1195499","journal-title":"Leuk Lymphoma"},{"key":"4640_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/TP.0000000000001143","volume":"101","author":"C Orvain","year":"2017","unstructured":"Orvain C, Beloncle F, Hamel J-F et al (2017) Different impact of the number of organ failures and graft-versus-host disease on the outcome of allogeneic stem cell transplantation recipients requiring intensive care. Transplantation 101:437\u2013444. https:\/\/doi.org\/10.1097\/TP.0000000000001143","journal-title":"Transplantation"},{"key":"4640_CR28","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/bmt.2016.72","volume":"51","author":"C Saillard","year":"2016","unstructured":"Saillard C, Blaise D, Mokart D (2016) Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis. Bone Marrow Transplant 51:1050\u20131061. https:\/\/doi.org\/10.1038\/bmt.2016.72","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR29","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/s41409-018-0181-x","volume":"53","author":"C Saillard","year":"2018","unstructured":"Saillard C, Darmon M, Bisbal M et al (2018) Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality. Bone Marrow Transplant 53:1233\u20131241. https:\/\/doi.org\/10.1038\/s41409-018-0181-x","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00277-008-0440-9","volume":"87","author":"F Neumann","year":"2008","unstructured":"Neumann F, Lobitz O, Fenk R, Bruns I, K\u00f6stering M, Steiner S, Hennersdorf M, Kelm M, Strauer BE, Germing U, Hinke A, Haas R, Kobbe G (2008) The Sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantation. Ann Hematol 87:299\u2013304. https:\/\/doi.org\/10.1007\/s00277-008-0440-9","journal-title":"Ann Hematol"},{"key":"4640_CR31","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","volume":"15","author":"A Bacigalupo","year":"2009","unstructured":"Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, Apperley J, Slavin S, Pasquini M, Sandmaier BM, Barrett J, Blaise D, Lowski R, Horowitz M (2009) Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 15:1628\u20131633. https:\/\/doi.org\/10.1016\/j.bbmt.2009.07.004","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"4640_CR32","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.1200\/JCO.2005.07.061","volume":"23","author":"C Schmid","year":"2005","unstructured":"Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ (2005) Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol Off J Am Soc Clin Oncol 23:5675\u20135687. https:\/\/doi.org\/10.1200\/JCO.2005.07.061","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"4640_CR33","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1182\/blood-2005-10-4165","volume":"108","author":"C Schmid","year":"2006","unstructured":"Schmid C, Schleuning M, Schwerdtfeger R, Hertenstein B, Mischak-Weissinger E, Bunjes D, Harsdorf SV, Scheid C, Holtick U, Greinix H, Keil F, Schneider B, Sandherr M, Bug G, Tischer J, Ledderose G, Hallek M, Hiddemann W, Kolb HJ (2006) Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation. Blood 108:1092\u20131099. https:\/\/doi.org\/10.1182\/blood-2005-10-4165","journal-title":"Blood"},{"key":"4640_CR34","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","volume":"15","author":"S Giralt","year":"2009","unstructured":"Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M, Sandmaier B (2009) Reduced intensity conditioning regimen workshop-defining the dose spectrum. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 15:367\u2013369. https:\/\/doi.org\/10.1016\/j.bbmt.2008.12.497","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"4640_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/bmt.2013.107","volume":"49","author":"T Ruutu","year":"2014","unstructured":"Ruutu T, Gratwohl A, de Witte T et al (2014) Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone Marrow Transplant 49:168\u2013173. https:\/\/doi.org\/10.1038\/bmt.2013.107","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR36","first-page":"107","volume":"72","author":"M van Vliet","year":"2014","unstructured":"van Vliet M, van der Burgt MPEM, van der Velden WJFM, van der Hoeven J, de Haan AF, Donnelly JP, Pickkers P, Blijlevens NM (2014) Trends in the outcomes of Dutch haematological patients receiving intensive care support. Neth J Med 72:107\u2013112","journal-title":"Neth J Med"},{"key":"4640_CR37","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3109\/10428194.2013.836602","volume":"55","author":"A-S Moreau","year":"2014","unstructured":"Moreau A-S, Seguin A, Lemiale V, Yakoub-Agha I, Girardie P, Robriquet L, Mangalaboyi J, Fourrier F, Jourdain M (2014) Survival and prognostic factors of allogeneic hematopoietic stem cell transplant recipients admitted to intensive care unit. Leuk Lymphoma 55:1417\u20131420. https:\/\/doi.org\/10.3109\/10428194.2013.836602","journal-title":"Leuk Lymphoma"},{"key":"4640_CR38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000440937","volume":"135","author":"SC Lindgaard","year":"2016","unstructured":"Lindgaard SC, Nielsen J, Lindmark A, Sengel\u00f8v H (2016) Prognosis of allogeneic haematopoietic stem cell recipients admitted to the intensive care unit: a retrospective, single-centre study. Acta Haematol 135:72\u201378. https:\/\/doi.org\/10.1159\/000440937","journal-title":"Acta Haematol"},{"key":"4640_CR39","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00134-018-5347-x","volume":"44","author":"C Lueck","year":"2018","unstructured":"Lueck C, Stadler M, Koenecke C, Hoeper MM, Dammann E, Schneider A, Kielstein JT, Ganser A, Eder M, Beutel G (2018) Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med 44:1483\u20131492. https:\/\/doi.org\/10.1007\/s00134-018-5347-x","journal-title":"Intensive Care Med"},{"key":"4640_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/10428194.2016.1195499","volume":"58","author":"S Mayer","year":"2017","unstructured":"Mayer S, Pastores SM, Riedel E, Maloy M, Jakubowski AA (2017) Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period. Leuk Lymphoma 58:382\u2013390. https:\/\/doi.org\/10.1080\/10428194.2016.1195499","journal-title":"Leuk Lymphoma"},{"key":"4640_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/TP.0000000000001143","volume":"101","author":"C Orvain","year":"2017","unstructured":"Orvain C, Beloncle F, Hamel J-F, Th\u00e9pot S, Mercier M, Kouatchet A, Farhi J, Francois S, Guardiola P, Asfar P, Hunault-Berger M, Mercat A, Ifrah N, Tanguy-Schmidt A (2017) Different impact of the number of organ failures and graft-versus-host disease on the outcome of allogeneic stem cell transplantation recipients requiring intensive care. Transplantation 101:437\u2013444. https:\/\/doi.org\/10.1097\/TP.0000000000001143","journal-title":"Transplantation"},{"key":"4640_CR42","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/bmt.2015.269","volume":"51","author":"L Platon","year":"2016","unstructured":"Platon L, Amigues L, Ceballos P, Fegueux N, Daubin D, Besnard N, Larcher R, Landreau L, Agostini C, Machado S, Jonquet O, Klouche K (2016) A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013). Bone Marrow Transplant 51:256\u2013261. https:\/\/doi.org\/10.1038\/bmt.2015.269","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR43","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1038\/s41409-020-0857-x","volume":"55","author":"C Pichereau","year":"2020","unstructured":"Pichereau C, Lenglin\u00e9 E, Valade S, Michonneau D, Ghrenassia E, Lemiale V, Soci\u00e9 G, Azoulay E (2020) Trajectories of acute graft-versus-host disease and mortality in critically ill allogeneic-hematopoietic stem cell recipients: the Allo-GRRR-OH score. Bone Marrow Transplant 55:1966\u20131974. https:\/\/doi.org\/10.1038\/s41409-020-0857-x","journal-title":"Bone Marrow Transplant"},{"key":"4640_CR44","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3324\/haematol.2017.187450","volume":"104","author":"E Brissot","year":"2019","unstructured":"Brissot E, Labopin M, Ehninger G, Stelljes M, Brecht A, Ganser A, Tischer J, Kr\u00f6ger N, Afanasyev B, Finke J, Elmaagacli A, Einsele H, Mohty M, Nagler A (2019) Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed\/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT. Haematologica 104:524\u2013532. https:\/\/doi.org\/10.3324\/haematol.2017.187450","journal-title":"Haematologica"},{"key":"4640_CR45","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/ajh.25231","volume":"93","author":"F Lorentino","year":"2018","unstructured":"Lorentino F, Labopin M, Bernardi M, Ciceri F, Soci\u00e9 G, Cornelissen JJ, Esteve J, Ruggeri A, Volin L, Yacoub-Agha I, Craddock C, Passweg J, Blaise D, Gedde-Dahl T, Poiani M, Fegueux N, Mohty M, Nagler A, On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2018) Comparable outcomes of haploidentical, 10\/10 and 9\/10 unrelated donor transplantation in adverse karyotype AML in first complete remission. Am J Hematol 93:1236\u20131244. https:\/\/doi.org\/10.1002\/ajh.25231","journal-title":"Am J Hematol"},{"key":"4640_CR46","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1182\/blood.2019001323","volume":"134","author":"SR McCurdy","year":"2019","unstructured":"McCurdy SR, Luznik L (2019) How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide. Blood 134:1802\u20131810. https:\/\/doi.org\/10.1182\/blood.2019001323","journal-title":"Blood"},{"key":"4640_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/bjh.15077","volume":"181","author":"A Rashidi","year":"2018","unstructured":"Rashidi A, Weisdorf DJ, Bejanyan N (2018) Treatment of relapsed\/refractory acute myeloid leukaemia in adults. Br J Haematol 181:27\u201337. https:\/\/doi.org\/10.1111\/bjh.15077","journal-title":"Br J Haematol"},{"key":"4640_CR48","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/ajh.25004","volume":"93","author":"J Decroocq","year":"2018","unstructured":"Decroocq J, Itzykson R, Vigouroux S, Michallet M, Yakoub-Agha I, Huynh A, Beckerich F, Suarez F, Chevallier P, Nguyen-Quoc S, Ledoux MP, Clement L, Hicheri Y, Guillerm G, Cornillon J, Contentin N, Carre M, Maillard N, Mercier M et al (2018) Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: a study from the Soci\u00e9t\u00e9 Francophone de Greffe de Moelle et de Th\u00e9rapie Cellulaire. Am J Hematol 93:416\u2013423. https:\/\/doi.org\/10.1002\/ajh.25004","journal-title":"Am J Hematol"},{"key":"4640_CR49","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bbmt.2016.11.002","volume":"23","author":"F Malard","year":"2017","unstructured":"Malard F, Labopin M, Stuhler G, Bittenbring J, Ganser A, Tischer J, Michallet M, Kr\u00f6ger N, Schmid C, Huynh A, Hallek M, Savani BN, Mohty M, Nagler A (2017) Sequential intensified conditioning regimen allogeneic hematopoietic stem cell transplantation in adult patients with intermediate- or high-risk acute myeloid leukemia in complete remission: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 23:278\u2013284. https:\/\/doi.org\/10.1016\/j.bbmt.2016.11.002","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"4640_CR50","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00277-018-3320-y","volume":"97","author":"C Orvain","year":"2018","unstructured":"Orvain C, Beloncle F, Hamel J-F, del Galy AS, Th\u00e9pot S, Mercier M, Kouatchet A, Farhi J, Francois S, Ifrah N, Mercat A, Asfar P, Hunault-Berger M, Tanguy-Schmidt A (2018) Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence. Ann Hematol 97:1601\u20131609. https:\/\/doi.org\/10.1007\/s00277-018-3320-y","journal-title":"Ann Hematol"},{"key":"4640_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/bmt.2017.192","volume":"53","author":"A Hegde","year":"2018","unstructured":"Hegde A, Murthy HS (2018) Frailty: the missing piece of the pre- hematopoietic cell transplantation assessment? Bone Marrow Transplant 53:3\u201310. https:\/\/doi.org\/10.1038\/bmt.2017.192","journal-title":"Bone Marrow Transplant"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04640-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04640-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T01:55:42Z","timestamp":1634090142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04640-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["4640"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04640-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"28 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients signed an anonymous data-recording consent before alloHCT procedure. The hospital medico-administrative is declared to the national committee for protection of privacy (Commission Nationale de l\u2019Informatique et des Libert\u00e9s). The study has been approved by the Ethics Commission of the French Intensive Care Society (Soci\u00e9t\u00e9 de R\u00e9animation de Langue Fran\u00e7aise).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FM, RD, and MM received honoraria for lectures from Keocyt and Sanofi, whose drugs were used to treat patients included in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}